Benzinga - Wed, 31 Mar 2021 10:03:28 -0400
Benzinga - Wed, 31 Mar 2021 09:28:56 -0400
Benzinga - Wed, 31 Mar 2021 07:08:44 -0400
Benzinga - Tue, 30 Mar 2021 18:14:30 -0400
load more
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.040

(EXPECTED) 2021-05-13

REV790.000K
Q4 2020Est.ActualSurprise
EPS-0.0500.010 0.0600
REV920.000K355.000K-565.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LCTXLineage Cell Therapeutics-3.18%442.9M

Lineage Cell Therapeutics Company Questions & Answers

Q

How do I buy Lineage Cell Therapeutics (LCTX) stock?

A

You can purchase shares of Lineage Cell Therapeutics (AMEX: LCTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lineage Cell Therapeutics's (LCTX) main competitors?

A

There are no as such competitors for Lineage Cell Therapeutics.

Q

What is the target price for Lineage Cell Therapeutics?

A

The latest price target for Lineage Cell Therapeutics (AMEX: LCTX) was reported by Cantor Fitzgerald on 2021-03-31. The analyst firm set a price target for 6.00 expecting LCTX to rise to within 12 months (a possible 118.98% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is Lineage Cell Therapeutics (LCTX) stock ?

A

The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $2.74 last updated Fri May 07 2021 19:59:51 GMT+0000 (Coordinated Universal Time).

Q

When is the next Lineage Cell Therapeutics (LCTX) dividend?

A

There are no upcoming dividends for Lineage Cell Therapeutics.

Q

When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?

A
Lineage Cell Therapeutics’s Q2 earnings are confirmed after-market from now on August 5, 2021.
Q

When is the upcoming split for LCTX?

A

There is no upcoming split for Lineage Cell Therapeutics.